Evotec (NASDAQ: EVO) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $0.08 by 600 percent. This is a 344.44 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $183.430 million which missed the analyst consensus estimate of $197.190 million by 6.98 percent. This is a 11.91 percent decrease over sales of $208.230 million the same period last year.